Filing Details
- Accession Number:
- 0001209191-15-021529
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-03 17:27:09
- Reporting Period:
- 2015-03-01
- Filing Date:
- 2015-03-03
- Accepted Time:
- 2015-03-03 17:27:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1565950 | Matthew Link | 7475 Lusk Blvd. San Diego CA 92121 | President, U.s. Sales And Svc. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-01 | 1,250 | $0.00 | 68,905 | No | 4 | A | Direct | |
Common Stock | Disposition | 2015-03-01 | 652 | $45.75 | 68,253 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-03-03 | 7,500 | $44.46 | 60,753 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Settlement of vested shares under Restricted Stock Unit grant dated July 1, 2013.
- Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive or purchase (as appropriate) shares pursuant to previously disclosed Company equity awards.
- Shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting/settlement of Restricted Stock Unit awards dated July 1, 2013.
- Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person on December 12, 2014, which is intended to comply with Rule 10b5-1.
- Weighted average from 51 transactions with prices ranging from $44.1100 to $44.7800. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.